Pulmonary drug delivery system: A review
1 Department of Pharmacy, Shraddha Institute of Pharmacy, Washim, Maharashtra, India.
2 Department of Quality Assurance, Shraddha Institute of Pharmacy, Washim, Maharashtra, India.
3 Department of Pharmacology, Shraddha Institute of Pharmacy, Washim, Maharashtra, India.
Review Article
GSC Biological and Pharmaceutical Sciences, 2023, 25(03), 149–158.
Article DOI: 10.30574/gscbps.2023.25.3.0473
Publication history:
Received on 28 September 2023; revised on 19 November 2023; accepted on 22 November 2021
Abstract:
An important route for the management of various drugs is the lung drug delivery system (PDDS). In recent years, the lungs have become increasingly concerned about the scientific and environmental value of treating lung diseases. Lung delivery of drugs has evolved into one of the most widely used routes of the planned or local drug rescuer Due to its potential localized lung function; drug delivery systems for the treatment of lung diseases are being developed. In this article, it is pointed out that PDSDS provides improved compliance with appropriate patient outcomes. In the traditional form, this novel drug delivery system has several advantages. Because of its potential therapeutic properties in the field of pulmonary embolism, the use of drug delivery systems (DDS) in the treatment of lung diseases is growing. This route also facilitates the placement of drugs in high-intensity areas within the patient-specific lungs, thereby reducing the total amount of medication administered to patients (10-20% of the peroral volume), and increasing local drug activity while minimizing side effects and systemic side effects and bypass the first-pass metabolism.
Keywords:
Pulmonary Drug Delivery System; Piezoelectric Effect; Side Effects; Nasal Drug Delivery;
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
